OxStem company

OxStem plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body.
Building on decades of experience in medicinal chemistry, OxStem will design drugs that can programme resident stem and stem-like cells in situ to treat currently untreatable age-related conditions.
Technology: P4 Medicine
Industry: Regenerative Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 7-5
Employees Number: 1-10
Funding Status: N/A
Investors Number: 2
Total Funding: £16.9M
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership